In 2022, challenges will continue to mount for plan sponsors and their advisors as they battle to keep costs under control without gutting benefits. “The top cost drivers for 2022 are similar to those of 2021, with musculoskeletal conditions and cancer ranking number one and two, respectively, followed by diabetes, cardiovascular and high-risk maternity,” says Ellen Kelsay, president and CEO of Business Group on Health.
Prescription drug costs continue to accelerate at an alarming rate, specifically costs associated with specialty medications.”
